(NYSE: NVST) Envista Holdings's forecast annual revenue growth rate of 4.5% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 10.64%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.29%.
Envista Holdings's revenue in 2026 is $2,719,500,000.On average, 16 Wall Street analysts forecast NVST's revenue for 2026 to be $475,402,526,697, with the lowest NVST revenue forecast at $454,098,725,087, and the highest NVST revenue forecast at $492,773,318,779. On average, 16 Wall Street analysts forecast NVST's revenue for 2027 to be $492,281,692,588, with the lowest NVST revenue forecast at $469,011,386,214, and the highest NVST revenue forecast at $517,026,877,535.
In 2028, NVST is forecast to generate $508,341,481,494 in revenue, with the lowest revenue forecast at $478,352,283,843 and the highest revenue forecast at $540,952,685,497.